Xinran Chu

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes

Shuiyan Wu, You Jiang, Yi Hong et al. · Cancer Cell International · 2021 · 65 citations · Full text

BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes

Li Ma, Jianwei Wang, Yongping Zhang et al. · Cancer Biology & Therapy · 2022 · 28 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +17

The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with <scp>E2A‐PBX1</scp>: A 10‐year retrospective study

Biqi Zhou, Xinran Chu, Hong Tian et al. · American Journal of Hematology · 2021 · 26 citations · Full text

Genomic Landscapes, Mixed-phenotype Acute Leukemia, Genetics +19

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells

Kunlong Zhang, Li Gao, Jianwei Wang et al. · Pathology & Oncology Research · 2022 · 22 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +17

A rapid and efficient polyethylenimine-based transfection method to prepare lentiviral or retroviral vectors: useful for making iPS cells and transduction of primary cells

Shaozhe Yang, Haijun Shi, Xinran Chu et al. · Biotechnology Letters · 2016 · 21 citations

Synthetic Virology, Medicine, Immunology +7